| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
674,040,000 |
| Market
Cap: |
16.70(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$17.15 - $26.07 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Avantor is a global manufacturer and distributor that provides products and services to customers in the biopharmaceutical, healthcare, education and government and advanced technologies and applied materials industries. Co.'s portfolio includes: Materials and consumables, such as lab products and supplies, formulated silicone materials, customized excipients, and customized single-use assemblies; equipment and instrumentation, such as filtration systems, virus inactivation systems, and incubators; and services and specialty procurement, such as onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
27,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$573,100 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
27,872 |
27,872 |
60,449 |
163,424 |
| Total Sell Value |
$687,456 |
$687,456 |
$1,380,595 |
$4,309,849 |
| Total People Sold |
3 |
3 |
4 |
5 |
| Total Sell Transactions |
4 |
4 |
6 |
15 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gupta Rajiv |
Director |
– • – |
2021-10-01 |
4 |
AS |
$39.94 |
$3,994,000 |
D/D |
(100,000) |
1,079,347 |
|
-13% |
|
| Stubblefield Michael |
President and CEO |
• • – |
2021-09-20 |
4 |
AS |
$42.37 |
$5,986,881 |
D/D |
(141,300) |
1,261,981 |
|
-12% |
|
| Gupta Rajiv |
Director |
– • – |
2021-09-01 |
4 |
AS |
$39.45 |
$3,945,000 |
D/D |
(100,000) |
1,179,347 |
|
-2% |
|
| Gupta Rajiv |
Director |
– • – |
2021-08-20 |
4 |
AS |
$38.81 |
$3,881,000 |
D/D |
(100,000) |
1,279,347 |
|
9% |
|
| Brophy Gerard |
EVP, Biopharma Production |
• – – |
2021-07-30 |
4 |
AS |
$37.24 |
$3,021,095 |
D/D |
(81,125) |
149,379 |
|
6% |
|
| Brophy Gerard |
EVP, Biopharma Production |
• – – |
2021-07-30 |
4 |
OE |
$23.20 |
$1,882,100 |
D/D |
81,125 |
230,504 |
|
- |
|
| Bramwell James |
EVP, Strategic Partners |
• – – |
2021-07-20 |
4 |
AS |
$37.00 |
$226,144 |
D/D |
(6,112) |
79,899 |
|
7% |
|
| Carethers John |
Director |
– • – |
2021-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,565 |
2,565 |
|
- |
|
| Natauri Jo |
Director |
– • – |
2021-07-12 |
4 |
B |
$36.33 |
$10,900 |
I/I |
300 |
557,656 |
2.1 |
9% |
|
| Bramwell James |
EVP, Strategic Partners |
• – – |
2021-07-09 |
4 |
AS |
$35.56 |
$652,828 |
D/D |
(18,331) |
86,011 |
|
7% |
|
| Couturier Christophe |
EVP, AMEA |
• – – |
2021-06-28 |
4 |
AS |
$35.73 |
$1,003,870 |
D/D |
(28,096) |
110,077 |
|
10% |
|
| Gupta Rajiv |
Director |
– • – |
2021-06-25 |
4 |
AS |
$35.32 |
$2,423,129 |
D/D |
(68,605) |
1,379,347 |
|
12% |
|
| Stubblefield Michael |
President and CEO |
• • – |
2021-06-10 |
4 |
AS |
$32.48 |
$3,244,330 |
D/D |
(99,887) |
1,403,281 |
|
15% |
|
| Stubblefield Michael |
President and CEO |
• • – |
2021-06-10 |
4 |
OE |
$3.13 |
$373,464 |
D/D |
99,887 |
1,460,656 |
|
- |
|
| Stubblefield Michael |
President and CEO |
• • – |
2021-06-09 |
4 |
AS |
$32.03 |
$7,532,495 |
D/D |
(235,170) |
1,403,281 |
|
20% |
|
| Stubblefield Michael |
President and CEO |
• • – |
2021-06-09 |
4 |
OE |
$3.13 |
$736,082 |
D/D |
235,170 |
1,638,451 |
|
- |
|
| Stubblefield Michael |
President and CEO |
• • – |
2021-06-08 |
4 |
AS |
$32.04 |
$4,890,682 |
D/D |
(152,643) |
1,403,281 |
|
17% |
|
| Stubblefield Michael |
President and CEO |
• • – |
2021-06-08 |
4 |
OE |
$3.13 |
$477,773 |
D/D |
152,643 |
1,555,924 |
|
- |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-05-27 |
4 |
S |
$31.99 |
$3,199,000 |
D/D |
(100,000) |
139,095 |
|
-27% |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-05-27 |
4 |
OE |
$23.21 |
$2,321,000 |
D/D |
100,000 |
239,095 |
|
- |
|
| Gupta Rajiv |
Director |
– • – |
2021-05-27 |
4 |
S |
$31.94 |
$2,494,801 |
I/I |
(78,109) |
278,109 |
|
-27% |
|
| Gupta Rajiv |
Director |
– • – |
2021-05-26 |
4 |
S |
$31.89 |
$4,783,500 |
I/I |
(150,000) |
356,218 |
|
-27% |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-05-26 |
4 |
S |
$31.87 |
$478,050 |
D/D |
(15,000) |
139,095 |
|
-27% |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-05-26 |
4 |
OE |
$23.21 |
$348,150 |
D/D |
15,000 |
154,095 |
|
- |
|
| Gupta Rajiv |
Director |
– • – |
2021-05-24 |
4 |
S |
$31.57 |
$10,687,716 |
I/I |
(337,571) |
506,218 |
|
-32% |
|
534 Records found
|
|
Page 10 of 22 |
|
|
0.49 (2.02%) 
